Numerous users of the Nuva Ring birth control device have filed a Nuvaring class action lawsuit against Organon, the manufacturer of NuvaRing contraceptives. They feel that the company was remiss in informing them the extent of bodily damage like the Nuvaring stroke.  There are several steps which they have already taken.

The aggrieved parties mistook certain side effects and considered the results of NuvaRing contraceptives as minor and harmless. Little did they know that the leg cramps and pain in the calf were already the beginnings of a Nuvaring stroke.   This condition together with blood clotting when untreated eventually results to massive heart attack.  In worst cases, injuries have resulted to death, hence the necessity to file a Nuvaring class action lawsuit.  Several litigation lawyers have already opened their doors to these individuals, offering their services for free.

Before actually filing for a Nuvaring class action lawsuit, the first authority we will turn our attention to is the Food and Drug Administration (FDA).  It appears that the NuvaRing was approved by the FDA in 2001hence, whatever potent features the contraceptive may contain went under the scrutiny of the FDA.  All questions regarding the propriety of the contraceptive as a safe device for birth control should have passed certain standards set by the FDA.

FDA released a statement to the effect that the culprit third generation hormone known as desogestrel has beneficial properties of its own. The corrective measures to be taken are not to pull out NuvaRing or the hormonal drug desogestrel but for the companies to enhance their labels with comprehensive information.  The latest course of action we found in the net is the FDA’s issuance of a new rule directing a drug company to revise the package insert or label of certain drugs in question.  In addition, warnings about the serious side effects like Nuva Ring stroke should be reinforced.

This caused mixed reactions among lawyers and concerned groups since there is an unspoken indication that drug companies and makers of medical devices can seek protection from lawsuits under this revised ruling. How then will this new ruling affect the nuvaring class action lawsuit filed against the makers of NuvaRing?

Lawyers of the nuvaring class action lawsuit are awaiting the outcome of a lawsuit by a certain Diana Levine against Wyeth, for an anti-nausea drug that eventually led to the amputation of her arm. Miss Levine’s grievance was founded on the premise that the drug was inadequately labeled.  Wyeth on the other hand contested that they were only adhering to FDA’s authority to approve label requirements.

The ruling that will be handed down by the Supreme Court upon this case, will determine the fate of the Nuvaring class action lawsuit. The alleged victims of nuvaring stroke and cases of blood clots may be solved depending upon the ruling of the court on the Wyeth vs. Levine case. The mere fact that the FDA issued their new ruling on the labeling requirements instead of a directive to provide full disclosure seems to block whatever light there is at the end of the tunnel.